Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
182 studies found for:    Open Studies | "Heparin"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Unknown † Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Condition: Deep Venous Thrombosis
Intervention: Drug: Low-Molecular-Weight Heparin
22 Unknown † Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass
Condition: Prevention of Venous Thromboembolism
Interventions: Biological: Bovine Heparin;   Biological: Porcine heparin
23 Recruiting Clinical Outcomes About Heparin Surface Modified Aspheric Lens
Condition: Inflammatory Reaction
Interventions: Device: traditional lens;   Device: heparin surface modified aspheric lens
24 Unknown † Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.
Conditions: Acute Kidney Injury;   Hemodialysis
Interventions: Drug: Unfractionated heparin;   Drug: Citrasate
25 Recruiting Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
Condition: Septic Shock
Interventions: Drug: Anticoagulation to prevent clotting of the extracorporeal circuit. (regional citrate anticoagulation);   Drug: Anticoagulation to prevent clotting of the extracorporeal circuit (Unfractionated heparin)
26 Unknown † Effect of a Pre Heparin Coated Dialysis Filter on Coagulation During Hemodialysis
Condition: Renal Failure
Intervention: Device: a pre-heparin-coated hemodialysis filter; Hepran
27 Unknown † PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (INTRAVENOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
Condition: Healthy
Intervention: Drug: Heparin
28 Unknown † CATCH - Catheter Infections in Children
Condition: Catheter-Related Infections
Interventions: Device: Standard polyurethane Central Venous Catheter;   Device: Antibiotic impregnated polyurethane CVC (minocycline and rifampicin);   Device: Heparin bonded polyurethane CVC
29 Unknown † PHARMACODYNAMICS ASSESSMENT PRODUCT HEPARIN SODIUM (SUBCUTANEOUSLY) OF THE SWINE 5.000UI/ML OF BLAU FARMACÊUTICA S/A IN HEALTHY SUBJECTS IN COMPARISON OF SODIUM HEPARIN APP PHARMACEUTICALS
Condition: Healthy
Intervention: Drug: Heparin
30 Recruiting Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
Conditions: Acute Chest Syndrome;   Sickle Cell Disease
Intervention: Drug: Unfractionated heparin
31 Unknown † Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure
Condition: Thrombosis
Intervention: Drug: Low molecular weight heparin
32 Unknown † Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children
Conditions: Infection of Intravenous Catheter;   Phlebitis;   Extravasation of Diagnostic and Therapeutic Materials
Interventions: Drug: 0,9% NaCl flush;   Drug: Heparin 50U/ml
33 Recruiting Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition
Conditions: Catheter-related Bloodstream Infection (CRBSI) Nos;   Catheter-related Bloodstream Infection Due to Central Venous Catheter;   Bloodstream Infection Due to Hickman Catheter
Interventions: Drug: Ethanol;   Drug: Heparin Lock;   Drug: Normal Saline
34 Recruiting Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients
Condition: Malignant Female Reproductive System Neoplasm
Intervention: Drug: Enoxaparin, Heparin
35 Unknown † Platelet Function With New Pediatric Oxygenator and Heparin and Non Heparin Coating in Pediatric Cardiac Surgery
Condition: Acquired Platelet Function Disorder
Intervention: Device: Balance surface, Carmeda heparin-coated surface
36 Recruiting Addition of Prednisolone and Heparin in Patients Undergoing Controlled Ovarian Hyperstimulation (COH) for In Vitro Fertilization (IVF) With Failed IVF Cycles
Condition: Infertility
Interventions: Drug: Prednisolone and Heparin during COH for IVF;   Drug: COH for IVF
37 Recruiting SuperB Trial: SUrgical Versus PERcutaneous Bypass
Condition: Cardiovascular Diseases
Interventions: Procedure: Heparin-bonded ePTFE endoluminal fem-pop bypass;   Procedure: Surgical femoro-popliteal bypass.
38 Recruiting Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin
Condition: Thrombosis
Intervention: Drug: Heparin
39 Recruiting Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU
Condition: Patients With Acute Renal Insufficiency
Interventions: Drug: Citrate 4%;   Drug: unfractionated heparin
40 Unknown † Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Cancer
Intervention: Drug: low molecular weight heparin
To Top

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
† Indicates status has not been verified in more than two years